BR9805318A - Método para tratamento de infecções dos olhos com azitromicina. - Google Patents

Método para tratamento de infecções dos olhos com azitromicina.

Info

Publication number
BR9805318A
BR9805318A BR9805318-3A BR9805318A BR9805318A BR 9805318 A BR9805318 A BR 9805318A BR 9805318 A BR9805318 A BR 9805318A BR 9805318 A BR9805318 A BR 9805318A
Authority
BR
Brazil
Prior art keywords
azithromycin
eye infections
treating eye
eye
treating
Prior art date
Application number
BR9805318-3A
Other languages
English (en)
Inventor
Imran Ahmed
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22074743&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR9805318(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of BR9805318A publication Critical patent/BR9805318A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)

Abstract

Patente de Invenção: <B>''MéTODO PARA TRATAMENTO DE INFECçõES DOS OLHOS COM AZITROMICINA''<D>. A invenção descreve métodos e composições para tratamento de infecções oculares. O método consiste em se administrar topicamente ao olho de um animal em carência desse tratamento uma quantidade de azitromicina para tratamento da infecção ocular.
BR9805318-3A 1997-12-02 1998-11-30 Método para tratamento de infecções dos olhos com azitromicina. BR9805318A (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US6725097P 1997-12-02 1997-12-02

Publications (1)

Publication Number Publication Date
BR9805318A true BR9805318A (pt) 2000-04-11

Family

ID=22074743

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9805318-3A BR9805318A (pt) 1997-12-02 1998-11-30 Método para tratamento de infecções dos olhos com azitromicina.

Country Status (11)

Country Link
EP (1) EP0925789B2 (pt)
JP (1) JPH11240838A (pt)
AT (1) ATE271390T1 (pt)
BR (1) BR9805318A (pt)
CA (1) CA2254682C (pt)
CY (1) CY1105482T1 (pt)
DE (1) DE69825128T3 (pt)
DK (1) DK0925789T4 (pt)
ES (1) ES2221127T5 (pt)
MX (1) MX232591B (pt)
PT (1) PT925789E (pt)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6861411B1 (en) 1997-12-02 2005-03-01 Pfizer, Inc. Method of treating eye infections with azithromycin
US7056893B2 (en) 1999-03-31 2006-06-06 Insite Vision, Inc. Topical treatment for prevention of ocular infections
US6239113B1 (en) 1999-03-31 2001-05-29 Insite Vision, Incorporated Topical treatment or prevention of ocular infections
IT1313610B1 (it) 1999-08-09 2002-09-09 S I F I Societa Ind Farmaceuti Processo per la preparazione di formulazioni acquose per uso oftalmico
DE10006560A1 (de) 2000-02-15 2001-08-23 Disetronic Licensing Ag Zweikomponentiger Kolbenstopfen
IL141438A0 (en) * 2000-02-23 2002-03-10 Pfizer Prod Inc Method of increasing the bioavailability and tissue penetration of azithromycin
EP1563850A3 (en) * 2000-02-23 2008-02-20 Pfizer Products Inc. Method of increasing the bioavailability and tissue penetration of azithromycin
FR2823441B1 (fr) * 2001-04-12 2004-09-10 Thea Lab Composition pharmaceutique a base de macrolides pour application locale en ophtalmologie et son procede de preparation
SI1390377T1 (sl) 2001-05-22 2006-06-30 Pfizer Prod Inc Nova kristalna oblika azitromicina
US7807802B2 (en) 2002-11-12 2010-10-05 Abbott Lab Polynucleotides for the amplification and detection of Chlamydia trachomatis and Neisseria gonorrhoeae
BRPI0416534A (pt) 2003-12-04 2007-01-09 Pfizer Prod Inc composições multiparticuladas com estabilidade melhorada
WO2005053652A1 (en) 2003-12-04 2005-06-16 Pfizer Products Inc. Multiparticulate crystalline drug compositions containing a poloxamer and a glyceride
ATE399536T1 (de) 2003-12-04 2008-07-15 Pfizer Prod Inc Verfahren zur herstellung von pharmazeutischen multiteilchenförmigen produkten
WO2006004085A1 (ja) 2004-07-02 2006-01-12 Wakamoto Pharmaceutical Co., Ltd. アジスロマイシン含有水性医薬組成物及びその調製方法
US20060046970A1 (en) * 2004-08-31 2006-03-02 Insite Vision Incorporated Topical otic compositions and methods of topical treatment of prevention of otic infections
FR2884716B1 (fr) * 2005-04-22 2009-08-21 Thea Sa Lab Utilisation de l'azithromycine pour la fabrication d'un medicament destine au traitement des infections oculaires
JPWO2007074904A1 (ja) * 2005-12-28 2009-06-04 わかもと製薬株式会社 水性医薬組成物
US20100247666A1 (en) * 2009-03-24 2010-09-30 Macleod Steven K Method for Preparing Suspensions of Low-Solubility Materials
US9775802B2 (en) 2009-03-24 2017-10-03 Bausch & Lomb Incorporated Method for preparing suspensions of low-solubility materials

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4474768A (en) * 1982-07-19 1984-10-02 Pfizer Inc. N-Methyl 11-aza-10-deoxo-10-dihydro-erytromycin A, intermediates therefor
CA2173109A1 (en) * 1993-10-01 1995-04-13 Kenneth Shyer Kornman Use of azithromycin for the treatment of adult periodontitis and topical compositions for this use
US5610198A (en) † 1994-03-18 1997-03-11 The United States Of America As Represented By The Department Of Health And Human Services Anti-mycobacterial compositions and their use for the treatment of tuberculosis and related diseases
AU4399396A (en) * 1994-12-19 1996-07-10 Russinsky Limited Compounds
US5872104A (en) * 1994-12-27 1999-02-16 Oridigm Corporation Combinations and methods for reducing antimicrobial resistance
CA2222567C (en) † 1995-06-07 2002-01-29 Southern Biosystems, Inc. High viscosity liquid controlled biologically active delivery system

Also Published As

Publication number Publication date
DK0925789T4 (da) 2009-07-13
DE69825128T3 (de) 2010-05-06
ES2221127T5 (es) 2009-11-10
EP0925789B1 (en) 2004-07-21
MX232591B (es) 2005-12-02
EP0925789A1 (en) 1999-06-30
DE69825128T2 (de) 2005-07-28
PT925789E (pt) 2004-10-29
ES2221127T3 (es) 2004-12-16
JPH11240838A (ja) 1999-09-07
CY1105482T1 (el) 2010-04-28
CA2254682A1 (en) 1999-06-02
EP0925789B2 (en) 2009-06-17
DK0925789T3 (da) 2004-10-25
DE69825128D1 (de) 2004-08-26
CA2254682C (en) 2003-07-08
ATE271390T1 (de) 2004-08-15

Similar Documents

Publication Publication Date Title
BR9805318A (pt) Método para tratamento de infecções dos olhos com azitromicina.
BR9607601A (pt) Uso de ácido hialurÈnico para o tratamento de cistite intersticial
BR9507506A (pt) Processo para exterminar uma célula processo para tratamento de càncer composição e kit terapéutico
BR9914109A (pt) Composições antibióticas para tratamento dos olhos, ouvidos e nariz
ES2178656T3 (es) Metodo para tratar infeccion bacteriana gram-negativa por administracion de productos de proteina bactericida que aumenta la permebilidad(bpi) y antibioticos.
BR0206639A (pt) Combinações de inibidor(es) da absorção do esterol com modificador(es) do sangue para o tratamento de condições vasculares
ES2046300T3 (es) Composicion para el tratamiento de la piel.
BR0000003A (pt) Azalidas e métodos de preparação das mesmas
ES2163034T3 (es) Composiciones micelares de copolimeros de bloque de polieter, para la objetivizacion de agentes biologicos como diana.
ES2166381T3 (es) Tratamiento de enfermedades vasculares hiperproliferativas.
BR9812965A (pt) Métodos para tratamento de estados hipercoaguláveis ou deficiência de proteìna c adquirida
CA2266811A1 (en) Method and composition for wound treatment
BR9809951A (pt) Método para tratamento da obesidade
BR0212907A (pt) Métodos para tratamento ou prevenção de inflamação vascular usando inibidor(es) da absorção de esteróis
KR890003387A (ko) 국소활성을 갖는 이중-가닥 RMAs조성물
CA2070685A1 (en) Method for treating painful, inflammatory or allergic disorders
DE69932939D1 (de) Fulvinsäure und dessen verwendung zur behandlung von diversen krankheitszuständen
BR9914128A (pt) Composições antibióticas para tratamento do olho, ouvido e nariz
BR9808221A (pt) Método de tratamento de tumor.
BR9406059A (pt) Composição farmacéutica e método para tratamento de uma infecção helmintica em um animal
BR9806249A (pt) Composição cosmética e/ou dermatológica destinada ao tratamento das fibras queratìnicas, composição pronta para uso, processo de tintura e de tratamento da fibras queratìnicas e dispositivo com vários compartimentos.
DE69825279D1 (de) Verwendung von glukosamin und glukosaminderivaten zur schnellen linderung von juckreiz oder lokalisiertem schmerz
BR9708864A (pt) Composto composição farmacêutica e processo para o tratamento ou a prevenção de uma infecção bacteriana em um paciente mamífero
PT1237562E (pt) Processo de preparacao de extractos de micania contendo micanolida e di-hidromicanolida e utilizacao no tratamento das doencas proliferativas
BRPI0416088A (pt) composição, sistema, e método de tratar condições tais como calcificação vascular

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFERIMENTO DO PRESENTE PEDIDO, POR INCIDENCIA NOS ARTIGOS 8, 11 E 13 DA LPI, LEI DE NUMERO 9.279 DE 14/05/1996, ATRAVES DE PUBLICACAO 9.2 NA RPI

B12B Appeal against refusal [chapter 12.2 patent gazette]